ScienceDaily

Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy

A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes. The surprising difference suggests that diabetes itself may be driving the risk, although researchers caution that the drugs' safety during pregnancy remains uncertain.

By ScienceDaily

1 min read
Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Medical Science

Related Insights